Browsing by Author "Contreras, Elma"
Now showing items 1-7 of 7
-
Abstract B094: Novel method for patient stratification in breast carcinoma based upon spatial analysis of tumor microenvironment
Ziegler, Colleen; Slemons, Isaiah; DeSilva, Chris; Witkowski, Barbara; Mir, Alain; Anandakrishnan, Sangeetha; Farmer, Andrew; Contreras, Elma; Richardson, David; Vranic, Semir; Gatalica, Zoran; Derkach, Dmitry N.... more authors ... less authors ( American Association for Cancer Research , 2019 , Conference Paper)Breast cancer consists of several intrinsic molecular subtypes, providing the basis for clinical treatment decisions. Lately, it is becoming increasingly recognized that factors other than the intrinsic cancer characteristics, ... -
Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
Gatalica, Zoran; Vranic, Semir; Krušlin, Božo; Poorman, Kelsey; Stafford, Phillip; Kacerovska, Denisa; Senarathne, Wijendra; Florento, Elena; Contreras, Elma; Leary, Alexandra; Choi, April; In, Gino K... more authors ... less authors ( Wiley Open Access , 2020 , Article)Primary Extra-mammary Paget's disease (EMPD) is a very rare cutaneous adenocarcinoma affecting anogenital or axillary regions. It is characterized by a prolonged course with recurrences and eventually distant metastatic ... -
Molecular Profiling of Clear Cell Carcinoma of the Breast Reveals Novel Targetable Biomarkers
Skenderi, Faruk; Palazzo, Juan; Swensen, Jeffrey; Contreras, Elma; Florento, Elena; Gatalica, Zoran; Vranic, Semir... more authors ... less authors ( Springer Nature , 2020 , Conference Paper)Background: Although clear cell morphology may be seen in various subtypes of breast cancer, a pure variant of clear cell carcinoma (usually glycogen-rich) is a very rare primary breast malignancy. It is characterized by ... -
Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix.
Cimic, Adela; Vranic, Semir; Arguello, David; Contreras, Elma; Gatalica, Zoran; Swensen, Jeffrey... more authors ... less authors ( Lippincott, Williams & Wilkins , 2020 , Article)Neuroendocrine carcinoma of the cervix (NEC) is a rare and highly aggressive cervical malignancy. Given that no targeted therapy has been approved specifically to NEC, we investigated the presence of novel, potentially ... -
Novel targetable biomarkers in clear cell carcinoma of the breast uncovered by molecular profiling: A study of nine cases.
Skenderi, Faruk; Palazzo, Juan; Swensen, Jeffrey; Feldman, Rebecca; Contreras, Elma; Florento, Elena; Gatalica, Zoran; Vranic, Semir... more authors ... less authors ( Wiley , 2020 , Article)We profiled nine pure clear cell carcinomas of the breast using massively parallel DNA and RNA sequencing (NGS), in situ hybridization (ISH), and immunohistochemistry (IHC). All cases were primary mammary clear cell ... -
Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast.
Vranic, Semir; Palazzo, Juan; Sanati, Souzan; Florento, Elena; Contreras, Elma; Xiu, Joanne; Swensen, Jeffrey; Gatalica, Zoran... more authors ... less authors ( Elsevier , 2018 , Article)Neuroendocrine carcinoma (NEC) of the breast is a rare, special type of breast cancer, reportedly constituting 2% to 5% of all breast cancers. Although breast NEC does not have a specific targeted therapy, several new ... -
TERT gene fusions characterize a subset of metastatic Leydig cell tumors
Bozo, Kruslin; Gatalica, Zoran; Hes, Ondrej; Skenderi, Faruk; Miettinen, Markku; Contreras, Elma; Xiu, Joanne; Elis, Michelle; Florento, Elena; Vranic, Semir; Swensen, Jeffrey... more authors ... less authors ( Elsevier , 2021 , Article)Objective: Metastatic Leydig cell tumors (LCT) are rare, difficult to treat malignancies without known underlying molecular-genetic events. An index case of metastatic LCT showed an LDLR-TERT gene fusion upon routine genetic ...